新聞/Reuters/Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In SarcopeniaBiophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia閱讀全文無限制訪問Reuters以及TradingView所有其他新聞來源的文章。繼續閱讀
